1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Global Influenza Vaccines Market Outlook 2018-2028

Global Influenza Vaccines Market Outlook 2018-2028

  • June 2018
  • 138 pages
  • ID: 4763515
  • Format: PDF
  • By Visiongain

Summary

Table of Contents

Forecasts for Trivalent Influenza Vaccines (TIV) & Quadrivalent Influenza Vaccines (QIV), Revenue Forecasts and Analysis of Pipeline Developments for Fluzone / VaxiGrip, Seqirus, Fluarix / FluLaval, FluMist / Fluenz, FluBlok and Other

The latest report from business intelligence provider visiongain offers comprehensive analysis of the global influenza vaccines market. Visiongain assesses that this market will generate revenues of $3.5 billion in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector. Visiongain’s new study tells you and tells you NOW.
In this brand new 138-page report you find 63 in-depth tables, charts and graphs -all unavailable elsewhere.
The report provides clear detailed insight into the global Influenza market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope
Visiongain’s new investigation shows revenue predictions at overall world market, submarket, company, product and national level.

That study gives individual analysis for two influenza vaccine submarkets, which are further divided by vaccine technologies:
- Trivalent Influenza Vaccines (TIV)
- Quadrivalent Influenza Vaccines (QIV)

Our new analysis also shows you revenue predictions for the vaccines produced by these five market leaders: and their market share:
- Sanofi Pasteur
- GSK
- Seqirus
- AstraZeneca
- Protein Science Corporation.
- Others

From 2018, large pharmaceutical companies and other biopharma specialists can prosper in that market. See how, discovering organisations’ potentials.

Our report analyses the vaccines in research and development and assess their prospects once they enter the market. The R&D pipeline discusses:
- Seasonal Influenza vaccines in development
- Universal Influenza vaccines in development

The report includes forecasts to 2028 and analysis of pipeline developments for the following specific vaccines:
- Fluzone / VaxiGrip
- Seqirus
- Fluarix / FluLaval
- FluMist / Fluenz
- FluBlok
- Other

The study shows you prospects for those drug sales in developed and developing regions. There see individual revenue forecasts to 2028 for 11 countries:
- United States
- Japan
- The EU 5 -Germany, France, United Kingdom, Italy and Spain.
- Brazil, Russia, India and China

Who should read this report?
- Anyone within the influenza vaccines value chain.
- Pharmaceutical companies
- Vaccine manufacturers
- Healthcare biotech companies
- Generics and biosimilar producers
- Drug delivery companies and other technology providers
- Contract/clinical research organisations (CROs)
- Pharma contract manufacturers,
- Pharma/healthcare wholesale and distribution companies
- Medical device companies
- Healthcare diagnostics companies
- R&D specialists
- Business development managers
- Marketing managers
- Technologists
- Suppliers
- Investors
- Banks
- Government agencies
- Contractors


Please note: This report is accessed through a password system. Single user (non-printable) and departmental licenses expires after 12 month period.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H2 2019

Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H2 2019SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Post-Polycythemia Vera Myelofibrosis - Pipeline Review, H2 ...

Genital Herpes - Pipeline Review, H2 2019

Genital Herpes - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Genital Herpes - Pipeline Review, H2 2019SummaryPharmaceutical and Healthcare disease pipeline guide Genital Herpes - Pipeline Review, H2 2019, provides an overview of the Genital Herpes (Infectious Disease) ...

Anthrax - Pipeline Review, H2 2019

Anthrax - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Anthrax - Pipeline Review, H2 2019SummaryThis latest Pharmaceutical and Healthcare disease pipeline guide Anthrax - Pipeline Review, H2 2019, provides an overview of the Anthrax (Infectious Disease) pipeline ...

Tetanus - Pipeline Review, H2 2019 $ 2000 November 2019


ref:plp2018

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on